Dieses Anti-Lipopolysaccharides (LPS)-Antikörper ist ein Maus Monoklonal-Antikörper zur Detektion von Lipopolysaccharides (LPS) in ELISA. Geeignet für Legionella pneumophila.
Produktnummer ABIN7232847
Kurzübersicht für Lipopolysaccharides (LPS) Antikörper (ABIN7232847)
This antibody recognizes LPS of L. pneumophila serogroup 1 (SG1). It does not react with serogroups 2-9, Legionella bozemanae, or Branhamella catarrharlis.
ELISA: use at 0.1-1.0 μg/mL with LPS on the solid phase at 5 μg/mL. These are recommended concentrations. End users should determine optimal concentrations for their applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Rekonstitution
Dilute in PBS or medium that is identical to that used in the assay system.
Konzentration
1.0 mg/mL
Buffer
PBS, 0.02 % sodium azide
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
-20 °C
Informationen zur Lagerung
This antibody is stable for at least one (1) year if stored at -20°C. Store product in appropriate aliquots to avoid multiple freeze-thaw cycles.
Target
Lipopolysaccharides (LPS)
Andere Bezeichnung
LPS
Substanzklasse
Chemical
Hintergrund
Legionella pneumophila are Gram- negative aerobic coccobacilli isolated from natural and artificial fresh water reservoirs. The outer membrane of L. pneumophila is comprised of a unique lipopolysaccharide (LPS) which is less endotoxic than enterobacterial LPS. Serogroups of L. pneumophila are classified based on O- antigen determinants of their cell wall side chains. L. pneumophila is pathogenic for humans, and it has no known soil or animal sources. It is responsible for more than 98 % of the cases of Legionnaires' Disease, and about 95 % of cases are due to serogroup 1. It has been isolated from numerous environmental sites as well as from human lung tissue, respiratory secretions, blood, and urine.